| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management named SL Green Realty Corp. (NYSE:SLG), which has a 6% dividend yield.
On Jan. 24, SL Green Realty posted weaker-than-expected results for its fourth quarter, posting sales of $131.93 million, missing market estimates of $161.36 million.
Bryn Talkington of Requisite Capital Management said the commercial business of Palantir Technologies Inc. (NYSE:PLTR) is exploding to the upside and believes that there is a "really long room to run."
On March 6, the Army Contracting Command – Aberdeen Proving Ground (ACC-APG) has awarded Palantir USG, Inc. a prime contract worth $178.4 million for developing and delivering the Tactical Intelligence Targeting Access Node (TITAN) ground station system. TITAN, enabled by Artificial intelligence (AI) and machine learning (ML), represents the Army’s next-gen deep-sensing capability.
Don’t forget to check out our premarket coverage here
Joseph Terranova of Virtus Investment Partners said DexCom, Inc. (NASDAQ:DXCM) is breaking out.
On Tuesday, the FDA approved DexCom’s Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM). The Dexcom Stelo Glucose Biosensor System is an integrated CGM (iCGM) intended for anyone 18 years and older who does not use insulin.
Price Action:
Check This Out: Cramer - This REIT Is 'A Little Too Dicey'; As For Marathon Digital, 'Own The Pure'
Image: Shutterstock
